Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries
Article
[키워드] 2B11
ACE2-binding site
acute respiratory syndrome
antibodies
antibody
B.1.1.7
B.1.1.7 variant
B.1.351
Combination
complexes
convalescent
coronavirus
COVID-19 convalescent patients
effective intervention
Efficacy
Efficiency
eight
epitope
Epitopes
exhibited
experiment
Genes
heavy chain
highest affinity
IGHV
immune
Immunoglobulin
immunology
in vivo
mice
NAb
neutralization
neutralization potency
Neutralizing
neutralizing antibody
overlap
P.1
PBMC
Prophylactic
pseudoviruses
public health
RBD
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variants
SARS-CoV-2 virus
SARS-CoV-2-neutralizing antibody
Screening
structural biology
the receptor-binding domain
the S1 protein
therapeutic
Treatment
variant
viruses
wild-type
WT SARS-CoV-2
[DOI] 10.1038/s41421-021-00295-w PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41421-021-00295-w PMC 바로가기 [Article Type] Article